No Prescription |
 |
 | ||
|
Urispas (Flavoxate) |
|
| ||
No Prescription » Anti Viral » Urispas (Flavoxate) Urispas (Flavoxate) is an anticholinergic agent used to treat bladder or bowel spasms and in combination with other medicines to treat ulcers. It may also be used to treat other conditions as determined by your doctor. Buy Urispas (Flavoxate) and other Anti Viral products online at Medstore. Buy Online at Medstore - Click Here!
About Urispas (Flavoxate): Product Type: Anti Viral Brand name: Urispas Generic name: Flavoxate What is the most important information I should know about Urispas? • Use caution when driving operating machinery or performing other hazardous activities. Urispas may cause dizziness drowsiness or blurred vision. If you experience dizziness drowsiness or blurred vision avoid these activities. • Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking Urispas. • Avoid becoming overheated in hot weather. Urispas may increase the risk of heat stroke because it may decrease sweating. Drink plenty of fluid of maintain adequate hydration. What is Urispas? • Urispas relieves spasms of the bladder and urinary tract. • Urispas is used to treat the symptoms of urinary frequency urinary urgency urinary leakage painful or difficult urination and urinary incontinence. • Urispas may also be used for purposes other than those listed in this medication guide. What should I discuss with my healthcare provider before taking Urispas? • Do not take Urispas if you have a blockage of the urinary tract (difficulty urinating); bleeding in the stomach; or a blockage in the intestines. • Before taking Urispas tell your doctor if you have glaucoma or other health problems. You may not be able to take Urispas or you may require a dosage adjustment or special monitoring if you have other medical conditions. • Urispas is in the FDA pregnancy category B. This means that it is not expected to be harmful to an unborn baby. Do not take Urispas without first talking to your doctor if you are pregnant or could become pregnant during treatment. • It is not known whether Urispas will be harmful to a nursing infant. Do not take Urispas without first talking to your doctor if you are breast-feeding a baby. • The safety and effectiveness of Urispas have not been studied in children younger than 12 years of age. Urispas is not recommended for use by children in this age group. How should I take Urispas? • Take Urispas exactly as directed by your doctor. If you do not understand these directions ask your pharmacist nurse or doctor to explain them to you. • Take each dose with a full glass of water. • Do not take more of this medication than is prescribed for you. If your symptoms are not being treated notify your doctor. • Store Urispas at room temperature away from moisture and heat. What happens if I miss a dose? • Take the missed dose as soon as you remember. However if it is almost time for the next dose skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication. What happens if I overdose? • Seek emergency medical attention. • Symptoms of an Urispas overdose are not well known but might include restlessness tremor irritability seizures delirium hallucinations flushing fever nausea vomiting a fast heartbeat and possibly coma. What should I avoid while taking Urispas? • Use caution when driving operating machinery or performing other hazardous activities. Urispas may cause dizziness drowsiness or blurred vision. If you experience dizziness drowsiness or blurred vision avoid these activities. • Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking Urispas. • Avoid becoming overheated in hot weather. Urispas may increase the risk of heat stroke because it may decrease sweating. Drink plenty of fluid to maintain adequate hydration. What are the possible side effects of Urispas? • If you experience any of the following serious side effects stop taking Urispas and seek emergency medical attention or contact your doctor immediately: an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips tongue or face; or hives); or an irregular or fast heart rate. • Other less serious side effects may be more likely to occur. Continue to take Urispas and talk to your doctor if you experience nausea or vomiting; dry mouth; dizziness or lightheadedness; headache; confusion; drowsiness; nervousness; blurred vision or large pupils; dryness of the eyes; or difficulty urinating. • Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. What other drugs will affect Urispas? • Urispas may increase the effects of other drugs that cause drowsiness including antidepressants alcohol antihistamines sedatives (used to treat insomnia) pain relievers anxiety medicines and muscle relaxants. Tell your doctor about all medicines that you are taking and do not take any medicine without first talking to your doctor. • Drugs other than those listed here may also interact with Urispas. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines including herbal products Generic Urispas (Flavoxate) Flavoxin 200mg 120 pills 200mg 240 pills 200mg 60 pills 200mg 30 pills 200mg 90 pills Flavoxate Urispas
View more Anti Viral No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
